Liangxi Zhu

Mr. Liangxi Zhu

Southeast University, Nanjing 210096, Jiangsu, China
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2021 in Biosensors
Verified
Journal Article
Open access
PDF file
Liangxi ZhuLiangxi Zhu
Liangxi Zhu
JZJingzhou Zhao
Jingzhou Zhao
ZGZhukang Guo
Zhukang Guo
YLYuan Liu
Yuan Liu
HCHui Chen
Hui Chen
Nongyue HeNongyue He
Nongyue He
Cancer is still a major disease that threatens human life. Although traditional cancer treatment methods are widely used, they still have many disadvantages. Aptamers, owing to their small size, low toxicity, good specificity, and excellent biocompatibility, have been widely applied in biomedical areas. Therefore, the combination of nanomaterials with aptamers offers a new method for cancer treatment. First, we briefly introduce the situation of cancer treatment and aptamers. Then, we discuss the application of aptamers in breast cancer treatment, lung cancer treatment, and other cancer treatment methods. Finally, perspectives on challenges and future applications of aptamers in cancer therapy are discussed.